PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance

Diabetes. 2001 Dec;50(12):2809-14. doi: 10.2337/diabetes.50.12.2809.

Abstract

Peroxisome proliferator-activated receptor (PPAR)-alpha controls the expression of genes involved in lipid metabolism. PPAR-alpha furthermore participates to maintain blood glucose during acute metabolic stress, as shown in PPAR-alpha-null mice, which develop severe hypoglycemia when fasted. Here, we assessed a potential role for PPAR-alpha in glucose homeostasis in response to long-term high-fat feeding. When subjected to this nutritional challenge, PPAR-alpha-null mice remained normoglycemic and normoinsulinemic, whereas wild-type mice became hyperinsulinemic (190%; P < 0.05) and slightly hyperglycemic (120%; NS). Insulin tolerance tests (ITTs) and glucose tolerance tests (GTTs) were performed to evaluate insulin resistance (IR). Under standard diet, the response to both tests was similar in wild-type and PPAR-alpha-null mice. Under high-fat diet, however, the efficiency of insulin in ITT was reduced and the amount of hyperglycemia in GTT was increased only in wild-type and not in PPAR-alpha-null mice. The IR index, calculated as the product of the areas under glucose and insulin curves in GTT, increased fourfold in high-fat-fed wild-type mice, whereas it remained unchanged in PPAR-alpha-null mice. In contrast, PPAR-alpha deficiency allowed the twofold rise in adiposity and blood leptin levels elicited by the diet. Thus, the absence of PPAR-alpha dissociates IR from high-fat diet-induced increase in adiposity. The effects of PPAR-alpha deficiency on glucose homeostasis seem not to occur via the pancreas, because glucose-stimulated insulin secretion of islets was not influenced by the PPAR-alpha genotype. These data suggest that PPAR-alpha plays a role for the development of IR in response to a Western-type high-fat diet.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • Animals
  • Blood Glucose / metabolism
  • Carbachol / pharmacology
  • Dietary Fats / administration & dosage*
  • Drug Synergism
  • Fasting
  • Glucose / pharmacology
  • Glucose Tolerance Test
  • Homeostasis
  • Hyperinsulinism / etiology
  • Hyperinsulinism / prevention & control
  • Hypoglycemia / genetics
  • Insulin / metabolism
  • Insulin Resistance*
  • Insulin Secretion
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Palmitic Acid / pharmacology
  • Receptors, Cytoplasmic and Nuclear / deficiency*
  • Receptors, Cytoplasmic and Nuclear / genetics
  • Receptors, Cytoplasmic and Nuclear / physiology
  • Transcription Factors / deficiency*
  • Transcription Factors / genetics
  • Transcription Factors / physiology

Substances

  • Blood Glucose
  • Dietary Fats
  • Insulin
  • Receptors, Cytoplasmic and Nuclear
  • Transcription Factors
  • Palmitic Acid
  • Carbachol
  • Glucose
  • 1-Methyl-3-isobutylxanthine